Altimmune Stock Discussion

Here are the levels to watch on this push up.
Larger Image: tradingview.com...
$Altimmune (ALT.US)$  

$Altimmune (ALT.US)$
Altimmune Announces Successful Completion of End-of-Phase 2 Meeting with FDA for Pemvidutide in the Treatment of Obesity
Altimmune (Nasdaq: ALT) announced successful completion of End-of-Phase 2 Meeting with FDA for pemvidutide in obesity treatment. The company received agreement on Phase 3 registrational program design, which will include four Phase 3 trials (VELOCITY-1,2,3,4) enrolling approximately 5,000 subjects over 60-week periods. The trials will evaluate pemvidut...

Continuing to coil tighter. Watch for 6.55 to hold as support.
Larger Image: tradingview.com...
$Altimmune (ALT.US)$  

$Altimmune (ALT.US)$  Money tied up on some other plays, well see how long is at these levels. There are always more opportunities to come. 🐂  📈

Watching for consolidation over the 7.40 top of the POC to setup a push to 10.00+
Larger Image: tradingview.com...
$Altimmune (ALT.US)$  

$Altimmune (ALT.US)$ Altimmune Presents Data From Its Phase 2, MRI-Based Body Composition Sub-study Of Pemvidutide In Subjects With Overweight And Obesity
Benzinga· 1 min ago
In an MRI sub-study of 67 subjects from the Phase 2 MOMENTUM obesity trial, 50 of whom were treated with pemvidutide for 48 weeks, the lean loss ratio, defined as the change in lean mass compared to the change in total mass, was 21.9%.
Lean mass preservation was greater in subjects aged 60 years and older, in whom the ...

$Altimmune (ALT.US)$
Altimmune Presents Results of a Phase 2 MRI-Based Body Composition Sub-Study at 60th Annual Meeting of the European Association for the Study of Diabetes
Altimmune presented results from a Phase 2 MRI-based body composition sub-study of pemvidutide at the 60th Annual Meeting of the European Association for the Study of Diabetes. The study, involving 67 subjects from the MOMENTUM obesity trial, showed promising outcomes for pemvidutide, a novel GLP-1/glucagon dual receptor...

Another strong day for ALT. 7.65 is resistance now. Support is at 7.40 the top of the POC.
Larger Image: tradingview.com...
$Altimmune (ALT.US)$  

$Altimmune (ALT.US)$ 👀looks food 1 month breakout
$Altimmune (ALT.US)$

Pushing up into the POC now. Here are the levels to keep an eye on this week.
Larger Image: tradingview.com...
$Altimmune (ALT.US)$